4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001415889-25-023190
Director sold 39,222 shares at an average $127.37 ($4,995,801)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ryan Jason Director | 2025-08-27 | Sale | −8,818 | $125.07 | $1,102,893 | 132,538 | I |
| Ryan Jason Director | 2025-08-27 | Sale | −8,969 | $126.15 | $1,131,472 | 123,569 | I |
| Ryan Jason Director | 2025-08-27 | Sale | −5,443 | $127.44 | $693,641 | 118,126 | I |
| Ryan Jason Director | 2025-08-27 | Sale | −3,452 | $128.04 | $441,997 | 114,674 | I |
| Ryan Jason Director | 2025-08-27 | Sale | −9,890 | $129.59 | $1,281,690 | 104,784 | I |
| Ryan Jason Director | 2025-08-27 | Sale | −1,500 | $130.01 | $195,015 | 103,284 | I |
| Ryan Jason Director | 2025-08-27 | Sale | −1,150 | $129.65 | $149,093 | 11,904 | D |
| Open-market sales · 39,222 sh · avg $127.37 · $4,995,801 | |||||||
Loading xslF345X05/form4-08282025_010846.xml…